Trandolapril/Verapamil Hydrochloride

群多普利/盐酸维拉帕米

Report date: 2022/01/21 20:00:34

Base Information

Drug NameTrandolapril/Verapamil Hydrochloride
Drug Alias NameTrandolapril/Verapamil盐酸维拉帕米群多普利Verapamil Hydrochloride and Trandolapril群多普利盐酸维拉帕米Trandolapril and Verapamil +[8] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin-converting enzyme inhibitors
TargetsVoltage-gated calcium channelAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/10/22
Country/TerritoryUnited States
CombinationsYes Verapamil HydrochlorideTrandolapril
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC09BB10
Related LinksWikipediaKEGG